Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/TELO/Capital expenditures

Telomir Pharmaceuticals, Inc. (TELO) Capital expenditures

Telomir Pharmaceuticals, Inc. (TELO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to TELO

Source: SEC XBRL filings · For reference only · Not investment advice

More TELO financial trends

TELO RevenueTELO Net incomeTELO Net marginTELO Gross profitTELO Gross marginTELO Operating incomeTELO Operating marginTELO Operating cash flowTELO Free cash flowTELO Return on equityTELO Stock buybacksTELO Dividends paidTELO Total assetsTELO Total liabilitiesTELO Shareholders’ equityTELO overview →